Saturday 17 October 2026 Export ADUS’s income statement to Excel — free account

Addus HomeCare Corporation

Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024. In the quarter to June 2026, revenue grew 8.01%, EPS grew 24.2%, free cash flow grew 81.7% and total debt fell 63.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

116.05 0.44 −0.38%

Follow ADUS

Alert me

Market cap: $2.2B
P/E: 20.4×
Fwd P/E: 14.9×
Dividend yield: —
F-score: 7/9
Altman Z: 5.17
Beneish M: −2.23
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total sells 5.29

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	2	—	18	1	1	2	1	—	—	—	—

Insider Ownership 0.89%

Capital & Financial Ratios $m

Market Cap 2,180.00

Revenue 1,476.41

Net Income 105.31

Free Cash Flow 154.80

Net Debt (37.97)

Current Ratio 1.69

Debt/Equity 0.05

P/E ratio 20.36

Fwd P/E 14.90

P/S ratio 1.44

P/B ratio 1.85

Past 5Y EPS Growth 20.20%

This Y EPS Growth 13.12%

Next Y EPS Growth 7.01%

Next Y revenue growth 7.13%

Next 5Y EPS Growth 8.72%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 6.52%

10-year low 10-year high

P/S against its own 10 years 36.93%

10-year low 10-year high

P/B against its own 10 years 13.67%

10-year low 10-year high

EV/Sales against its own 10 years 32.95%

10-year low 10-year high

EV/FCF against its own 10 years 14.50%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2017	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	65	99	82	100
Receivables	115	123	152	145
Inventory	—	—	—	—
Other	—	—	—	—
	200	260	269	284

	2023	2024	2025	Q'26
Payables	26	27	17	18
ST’ Debt	—	—	—	—
Other	6	11	12	12
	145	156	149	168

Compound Annual Growth %

	10y	5y	3y
Sales	15.50%	13.22%	14.36%
Cash Flow	39.12%	0.38%	1.99%
Earnings	23.50%	23.69%	27.73%
Book Value	22.58%	15.91%	19.65%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	364	377	—	—	—
’25	338	349	362	373	1,423
’24	281	287	290	297	1,155
’23	252	260	271	276	1,059
’22	227	237	240	247	951
’21	205	218	217	225	864
’20	190	185	194	196	765

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	52	40	—	—	—
’25	19	23	51	19	112
’24	39	19	49	10	116
’23	19	42	22	30	112
’22	6	57	18	24	105
’21	(18)	15	18	25	39
’20	20	30	22	36	109

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	51	39	—	—	—
’25	17	21	49	16	104
’24	37	18	47	9	110
’23	18	41	19	25	103
’22	5	56	17	19	97
’21	(19)	14	16	24	35
’20	18	29	21	35	103

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	1.36	1.49	—	—	—
’25	1.16	1.20	1.24	1.61	5.22
’24	0.97	1.10	1.10	1.07	4.23
’23	0.78	0.91	0.95	1.20	3.83
’22	0.53	0.70	0.71	0.91	2.84
’21	0.55	0.72	0.72	0.81	2.81
’20	0.54	0.43	0.57	0.53	2.08

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	15.33	29.90	33.25	57.94	43.13	73.06	68.57	77.30	85.94	88.96	Analyst estimates 2026–2028 Powerpack
	High	36.30	40.75	77.82	97.67	117.99	129.01	112.89	114.99	136.12	136.72
People
People	Employees	23,070	26,097	33,153	33,238	35,139	31,915	33,182	34,846	49,703	50,659
	Revenue/emp, $m	0.02	0.02	0.02	0.02	0.02	0.03	0.03	0.03	0.02	0.03
Income, $m
Income, $m	Revenue	401	426	517	649	765	864	951	1,059	1,155	1,423
	Gross margin, %	26.52	27.20	26.48	27.63	29.58	31.21	31.51	32.10	32.48	32.47
	EBT	16	21	20	33	42	60	60	81	99	127
	EBT margin, %	4.03	4.94	3.95	5.11	5.48	6.99	6.33	7.68	8.60	8.96
	Net income	12	12	16	25	33	45	46	63	74	96
	Depreciation	7	9	9	11	13	15	15	15	15	18
Per share, $
Per share, $	Revenue	35.51	37.14	42.88	46.96	49.04	54.93	59.97	66.18	67.89	78.80
	Earnings	1.06	1.17	1.41	1.76	2.08	2.81	2.84	3.83	4.23	5.22
	Cash flow	(0.07)	4.60	2.76	0.87	7.02	2.51	6.63	7.02	6.85	6.18
	Capex	(0.15)	0.01	(0.44)	(0.33)	(0.44)	(0.30)	(0.52)	(0.59)	(0.35)	(0.43)
	Free cash flow	(0.22)	4.61	2.31	0.54	6.58	2.21	6.10	6.43	6.49	5.75
	Book value	13.97	15.37	22.28	34.42	33.26	36.50	39.94	44.18	57.07	60.12
	Shares, m	11	11	12	14	16	16	16	16	17	18
Valuation, ×
Valuation, ×	P/E	34.10	34.89	47.80	52.74	56.57	33.40	34.84	24.28	29.56	20.61
	P/S	1.01	0.97	1.58	2.07	2.39	1.70	1.66	1.41	1.85	1.36
	P/B	2.57	2.33	3.05	2.82	3.52	2.56	2.49	2.11	2.20	1.79
	EV/Sales	1.05	0.94	1.48	1.99	2.45	1.76	1.71	1.47	1.95	1.39
	EV/FCF	(162.61)	7.60	27.60	178.07	18.31	43.94	16.84	15.11	20.43	19.09
Cash, $m
Cash, $m	Operating cash flow	(1)	53	33	12	109	39	105	112	116	112
	Capex	(2)	0	(5)	(5)	(7)	(5)	(8)	(9)	(6)	(8)
	Free cash flow	(2)	53	28	7	103	35	97	103	110	104
Balance, $m
Balance, $m	Working capital	81	101	115	182	144	207	92	55	105	120
	Total debt	25	43	17	60	195	221	132	124	218	121
	Net debt	17	(11)	(53)	(52)	50	52	52	59	120	39
	Shareholders’ equity	158	176	268	476	519	574	634	707	970	1,085
Returns, %
Returns, %	ROA	5.85	4.77	5.30	5.13	4.33	4.90	4.88	6.37	6.04	6.73
	ROIC	5.53	9.54	6.62	5.13	4.89	6.58	6.27	7.42	5.89	7.70
	ROE	8.12	7.16	7.39	6.78	6.66	8.26	7.62	9.33	8.78	9.33

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
AVAH Aveanna Healthcare Holdings Inc.	$2.8B	9.5×	10.4×	+13.73% (above 0%: growing)	+46.15% (above 0%: growing)	+57.89% (above 0%: growing)	32.59%	11.93%	Compare
GRDN Guardian Pharmacy Services, Inc.	$2.5B	37.5×	39.5×	+2.16% (above 0%: growing)	+133.33% (above 0%: growing)	+60.83% (above 0%: growing)	22.75%	5.87%	Compare
BKD Brookdale Senior Living Inc.	$2.4B	— (loss-making)	— (loss-making)	−11.61% (below 0%: shrinking)	n/m	+533.14% (above 0%: growing)	29.94%	11.86%	Compare
MD Pediatrix Medical Group, Inc.	$2.3B	13.1×	11.3×	+4.04% (above 0%: growing)	+6.52% (above 0%: growing)	−6.56% (below 0%: shrinking)	27.16%	11.67%	Compare
ADUS Addus HomeCare Corporation	$2.2B	20.4×	14.9×	+8.01% (above 0%: growing)	+24.17% (above 0%: growing)	+81.74% (above 0%: growing)	32.21%	10.32%
SGRY Surgery Partners, Inc.	$1.9B	— (loss-making)	— (loss-making)	+2.75% (above 0%: growing)	n/m	−60.63% (below 0%: shrinking)	22.41%	12.78%	Compare
ASTH Astrana Health, Inc.	$1.9B	44.3×	29.7×	+48.52% (above 0%: growing)	+110.53% (above 0%: growing)	−67.74% (below 0%: shrinking)	10.70%	3.53%	Compare
ARDT Ardent Health, Inc.	$1.7B	21.7×	7.7×	−1.40% (below 0%: shrinking)	−76.92% (below 0%: shrinking)	+121.70% (above 0%: growing)	100.00%	3.44%	Compare
SNDA Sonida Senior Living, Inc.	$1.7B	— (loss-making)	— (loss-making)	+122.02% (above 0%: growing)	n/m	−291.70% (below 0%: shrinking)	34.97%	(2.63%)	Compare
Median of peers	$2.1B	21.7×	11.3×	+3.40%	+46.15%	+25.67%	28.55%	8.77%

All 55 Medical Care Facilities stocks →

Addus HomeCare Corporation (ADUS) key facts

Strength: Addus HomeCare Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 23.2% from fiscal 2024.
Addus HomeCare Corporation (ADUS) is a Medical Care Facilities company in the Healthcare sector, listed on Nasdaq.
As of October 16, 2026, ADUS traded at $116.05, a market capitalization of $2.2 billion.
Return on equity was 9.33% and debt-to-equity 0.05.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 5.17 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.